ETFs with SLXP as a Top 10 Holding*Sponsored by:
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|4.55%||SPDR S&P Pharmaceuticals ETF (XPH)||+9.12 (16.66%)|
|4.4%||PowerShares Exchange-Traded Fund Trust II PowerShares S&P Smal (PSCH)||+5.62 (15.57%)|
|1.23%||iShares Small Cap 600/BARRA Growth Index Fund (IJT)||+5.19 (6.39%)|
|1.23%||SPDR S&P 600 Small Cap Growth ETF (based on S&P SmallCap 600 G (SLYG)||+6.62 (5.39%)|
|0.83%||Vanguard S&P Small-Cap 600 Growth ETF (VIOG)||+8.53 (11.89%)|
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
Salix Pharmaceuticals, Ltd., a Delaware corporation, is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs and medical devices used in the treatment of a variety of gastrointestinal disorders, which are those affecting the digestive tract. Our website address is www.salix.com. Information on our website, Twitter feed and Facebook page are not incorporated herein by reference. We make available free of charge through our website our press releases, Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and all amendments to those reports as soon as reasonably practicable after electronically filed with or furnished to the Securities and Exchange Commission. ... More ...